Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 28 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 81% of rolling 1-year windows.
Buy checklist
History depth
Fail
1.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.78% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -17.4%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 31.8% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
10 Jun 2025 – 27 May 2026
Trough 23 Mar 2026 · recovered in 65 days
-17.4%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-10.9%
24 Mar 2025 – 17 Apr 2025
Trough 7 Apr 2025 · recovered in 10 days
-8.0%
20 Feb 2025 – 24 Mar 2025
Trough 3 Mar 2025 · recovered in 21 days
-7.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
23
Vs category
94
Consistency
81
Risk-adjusted
37
Drawdown
57
Mean
58
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
30 Sept 2026 · 100 holdings · top 10 are 31.8%.
Laurus Labs Ltd
Healthcare
4.8%
BSE Ltd
Financial
4.2%
The Federal Bank Ltd
Financial
4.1%
Multi Commodity Exchange Of India Ltd
Financial
3.8%
Bharat Forge Ltd
Consumer Discretionary
2.8%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Aditya Birla Sun Life Mutual Fund
Caveat: Lower trailing returns
Aditya Birla Sun Life Mutual Fund
Caveat: Deeper drawdown
Axis Mutual Fund
Caveat: Deeper drawdown
Groww Mutual Fund
Caveat: Lower trailing returns
HSBC Mutual Fund
Caveat: Deeper drawdown
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 28 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 81% of rolling 1-year windows.
Buy checklist
History depth
Fail
1.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.78% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -17.4%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 31.8% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
28 Oct 2026 · +0.2% over 1Y
11.1901
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
28 Oct 2026
-7.2%
10 Jun 2025 – 27 May 2026
Trough 23 Mar 2026 · recovered in 65 days
-17.4%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-10.9%
24 Mar 2025 – 17 Apr 2025
Trough 7 Apr 2025 · recovered in 10 days
-8.0%
20 Feb 2025 – 24 Mar 2025
Trough 3 Mar 2025 · recovered in 21 days
-7.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
23
Vs category
94
Consistency
81
Risk-adjusted
37
Drawdown
57
Mean
58
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
30 Sept 2026 · 100 holdings · top 10 are 31.8%.
Laurus Labs Ltd
Healthcare
4.8%
BSE Ltd
Financial
4.2%
The Federal Bank Ltd
Financial
4.1%
Multi Commodity Exchange Of India Ltd
Financial
3.8%
Bharat Forge Ltd
Consumer Discretionary
2.8%